Il­lu­mi­na re­ceives EU clear­ance for planned Grail di­vest­ment

Last year
Deals
Diagnostics

Adap­ti­m­mune los­es $3B biobucks pact with Genen­tech

Last year
Deals
R&D

Obe­si­ty drug­mak­er lands first bio­phar­ma up­list­ing on­to Nas­daq since last sum­mer

Last year
Financing
Startups

Il­lu­mi­na CFO to de­part; Jude Samul­s­ki ends his run as AskBio’s CSO

Last year
People
Peer Review

I-Mab CEO de­tails con­sid­er­a­tions be­hind Chi­na split, hints at po­ten­tial in-li­cens­ing

Last year
Deals
China

En­livex’s shares cut in half af­ter ‘bi­as­es’ cloud Ph2 cell ther­a­py da­ta in sep­sis

Last year
R&D
Cell/Gene Tx

Ex­clu­sive: Sidu­ma, a biotech from Arv­inas' sci­en­tif­ic founder, shut­ters due to 'fi­nanc­ing en­vi­ron­men­t'

Last year
People
Startups

FDA com­mis­sion­er calls on House com­mit­tee to help com­bat drug short­ages

Last year
Pharma
FDA+

Fu­ji­film in­vests $1.2B to ex­pand North Car­oli­na bio­man­u­fac­tur­ing fa­cil­i­ty

Last year
Manufacturing

As­traZeneca's Fasen­ra ex­pands ap­proval in chil­dren with se­vere asth­ma

Last year
Pharma
FDA+

CMS to in­crease re­im­burse­ment for new sick­le cell gene ther­a­pies

Last year
Cell/Gene Tx
FDA+

Eli Lil­ly los­es case against Flori­da com­pound­ing phar­ma­cy

Last year
Pharma
Law

As­cend takes Bea­con’s man­u­fac­tur­ing as­sets; 89bio’s $135M build in Chi­na

Last year
Manufacturing

Mod­er­na halts African fa­cil­i­ty build as Covid-19 vac­cine de­mand plum­mets

Last year
Manufacturing

Fresh off ALS drug with­draw­al, Amy­lyx touts in­ter­im rare dis­ease da­ta for the same ther­a­py

Last year
R&D

Lipocine’s weight loss drug shows ear­ly signs of keep­ing mus­cle mass in Ph2

Last year
R&D

Lights, cam­era and com­mu­ni­ty: As­traZeneca’s Alex­ion cre­ates an orig­i­nal film to spot­light rare neu­ro­log­i­cal ...

Last year
Pharma
Marketing

Cen­tu­ry Ther­a­peu­tics buys Clade; Eliem an­nounces $120M PIPE and a deal

Last year
News Briefing

No­var­tis want­ed just one drug from Mor­phoSys be­fore up­ping bid for whole com­pa­ny, doc­u­ment re­veals

Last year
Deals
Pharma

Af­ter hack, an­a­lysts are brac­ing for a ‘messy’ Q1 earn­ings from Unit­ed­Health Group

Last year
Health Tech

No­var­tis lines up pro­tein de­grad­er deal with Pfiz­er-al­lied Arv­inas

Last year
Deals

Af­ter ap­provals for one of can­cer's 'un­drug­gable' tar­gets, re­search in­to new KRAS ther­a­pies booms: #AACR24

Last year
R&D
Pharma

US sues Re­gen­eron over ‘hun­dreds of mil­lions’ in al­leged­ly in­flat­ed Medicare re­im­burse­ments for Eylea

Last year
Pharma
Law

US reach­es new record of 320+ drugs in ac­tive short­age, group says

Last year
Pharma
Manufacturing
First page Previous page 172173174175176177178 Next page Last page
A service from the Financial Times